Biomanufacturing Excellence Act of 2025

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 6089 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. R. 6089 To establish a Biopharmaceutical Center of Excellence, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES November 18, 2025 Ms. Houlahan (for herself, Mr. Baird, Ms. Ross, and Mr. Rouzer) introduced the following bill; which was referred to the Committee on Science, Space, and Technology _______________________________________________________________________ A BILL To establish a Biopharmaceutical Center of Excellence, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Biomanufacturing Excellence Act of 2025''. SEC. 2. FINDINGS; SENSE OF CONGRESS. (a) Findings.--Congress finds the following: (1) Biotechnology is the designing and engineering of biological systems. Biotechnology allows scientists to grow everything from medicines to crops to materials, enabling ``biology by design''. (2) Biotechnology holds the potential for the United States to transform its military capabilities, strengthen food security and agricultural resilience, and cure life-threatening diseases, but it holds that same potential for other countries. The countries that master biotechnology first will gain the ability to shape how those technologies are used for decades to come. (3) Biotechnology unlocks the capabilities of producing medicines via biological systems, known as biopharmaceutical manufacturing. Biopharmaceutical manufacturing will enable better and less invasive treatments that extend and improve lives. (4) By investing in biomanufacturing, the United States Government would reduce dependency on foreign supply chains. (5) For United States manufacturers, the biggest roadblock to commercialization is proving t